Amalgamated Bank Purchases 1,903 Shares of Colgate-Palmolive (CL)

Amalgamated Bank lifted its position in Colgate-Palmolive (NYSE:CL) by 1.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 99,995 shares of the company’s stock after buying an additional 1,903 shares during the period. Amalgamated Bank’s holdings in Colgate-Palmolive were worth $7,285,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Blue Chip Partners Inc. lifted its holdings in shares of Colgate-Palmolive by 0.4% during the second quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock worth $134,000 after purchasing an additional 8 shares during the period. AlphaMark Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the period. Capital Investment Advisors LLC lifted its holdings in Colgate-Palmolive by 0.3% in the second quarter. Capital Investment Advisors LLC now owns 8,318 shares of the company’s stock valued at $617,000 after acquiring an additional 27 shares during the period. Weatherstone Capital Management lifted its holdings in Colgate-Palmolive by 0.7% in the second quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock valued at $302,000 after acquiring an additional 28 shares during the period. Finally, Dorsey & Whitney Trust CO LLC lifted its holdings in Colgate-Palmolive by 0.6% in the second quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock valued at $419,000 after acquiring an additional 34 shares during the period. Institutional investors own 72.83% of the company’s stock.

In other Colgate-Palmolive news, COO Justin Skala sold 126,393 shares of the stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $72.97, for a total value of $9,222,897.21. Following the sale, the chief operating officer now owns 262,361 shares of the company’s stock, valued at approximately $19,144,482.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jennifer Daniels sold 7,375 shares of the stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the sale, the insider now directly owns 38,691 shares in the company, valued at approximately $2,831,407.38. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 181,048 shares of company stock valued at $13,168,995. Company insiders own 1.02% of the company’s stock.

CL has been the subject of a number of analyst reports. Citigroup decreased their price target on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 target price for the company in a research note on Monday, October 23rd. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price for the company in a research note on Tuesday, December 19th. Finally, SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their target price for the stock from $65.00 to $85.00 in a research note on Wednesday, October 11th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have issued a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and an average price target of $76.51.

Shares of Colgate-Palmolive (CL) opened at $74.82 on Thursday. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. The stock has a market capitalization of $65,700.00, a price-to-earnings ratio of 28.89, a price-to-earnings-growth ratio of 3.21 and a beta of 0.81. Colgate-Palmolive has a twelve month low of $63.43 and a twelve month high of $77.27.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.73. The business had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company’s revenue was up 2.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.73 EPS. equities research analysts anticipate that Colgate-Palmolive will post 2.88 earnings per share for the current year.

WARNING: “Amalgamated Bank Purchases 1,903 Shares of Colgate-Palmolive (CL)” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.com-unik.info/2018/01/11/amalgamated-bank-purchases-1903-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit